MARKET

CSBTF

CSBTF

Kuros Bioscience
OTCPK
32.00
NaN%
Closed 09:30 02/13 EST
OPEN
--
PREV CLOSE
32.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
42.81
52 WEEK LOW
20.00
MARKET CAP
1.21B
P/E (TTM)
-170.4848
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Sandoz Group Ltd (OtherSDZXF) and Kuros Biosciences (OtherCSBTF)
TipRanks · 12/04/2025 01:40
Kuros Biosciences’ MagnetOs Study: A Potential Game-Changer in Spinal Fusion
TipRanks · 10/27/2025 20:08
Kepler Capital Sticks to Their Buy Rating for Kuros Biosciences (CSBTF)
TipRanks · 10/18/2025 01:45
Kuros Biosciences Reports Strong Revenue Growth and Strategic Expansion
Barchart · 10/17/2025 00:34
Kepler Capital Sticks to Its Buy Rating for Kuros Biosciences (CSBTF)
TipRanks · 09/21/2025 01:35
Weekly Report: what happened at CSBTF last week (0908-0912)?
Weekly Report · 09/15/2025 11:45
Kuros Biosciences (CSBTF) Receives a Buy from Kepler Capital
TipRanks · 09/10/2025 01:35
Weekly Report: what happened at CSBTF last week (0901-0905)?
Weekly Report · 09/08/2025 11:47
More
About CSBTF
Kuros Biosciences AG is a Switzerland-based biotechnology company engaged in the discovery, development and commercialization of biopharmaceutical products known as Immunodrugs. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. The Company has built a pipeline of different Immunodrug candidates, of which five are in clinical development. Its Immunodrug candidates are developed both in-house and together with Novartis, Pfizer and Pfizer Animal Health, among others. The Company has two subsidiaries: a wholly-owned Proteome Therapeutics GmbH and minority owned BioSupport AG.

Webull offers Kuros Biosciences AG stock information, including OTCPK: CSBTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSBTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSBTF stock methods without spending real money on the virtual paper trading platform.